A molecular docking study of potential inhibitors and repurposed drugs against SARS-CoV-2 main protease enzyme
COVID-19 has affected millions of people. Although many drugs are in use to combat disease, there is not any sufficient treatment yet. Having critical role in propagation of the novel coronavirus (SARS-CoV-2) works Main Protease up into a significant drug target. We have performed a molecular dockin...
Saved in:
Published in | Journal of the Indian Chemical Society Vol. 98; no. 3; p. 100041 |
---|---|
Main Authors | , |
Format | Journal Article |
Language | English |
Published |
Elsevier B.V
01.03.2021
Indian Chemical Society. Published by Elsevier B.V |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!